English: Cumulative incidence curves for the first COVID-19 occurrence after first dose of Tozinameran (BNT162b2) or placebo (all-available efficacy population) in double-blind clinical trial submitted to the U.S. FDA for EUA by Pfizer-BioNTech. (red: placebo; blue: BNT162b2)
Cumulative incidence curves for symptomatic COVID-19 infections after the first dose of Tozinameran (BNT162b2) or placebo in double-blind clinical trial. (red: placebo; blue: BNT162b2)
ไฟล, bnt162b2, vaccine, efficacy, data, ไฟล, ประว, ไฟล, หน, าท, ภาพน, การใช, ไฟล, วนกลางขนาดของต, วอย, างน, กเซล, ความละเอ, ยดอ, กเซล, กเซล, กเซล, กเซล, ภาพท, ความละเอ, ยดส, งกว, 8206, กเซล, ขนาดไฟล, โลไบต, ชน, ดไมม, image, ปภาพหร, อไฟล, เส, ยงน, นฉบ, บอย, คอม. ifl prawtiifl hnathimiphaphni karichiflswnklangkhnadkhxngtwxyangni 781 600 phikesl khwamlaexiydxun 313 240 phikesl 625 480 phikesl 1 000 768 phikesl 1 120 860 phikesl duphaphthimikhwamlaexiydsungkwa 8206 1 120 860 phikesl khnadifl 127 kiolibt chnidimm image png rupphaphhruxiflesiyngni tnchbbxyuthi khxmmxns raylaexiyddanlang epnkhxkhwamthiaesdngphlcak ifltnchbbinkhxmmxns khxmmxnsepnewbistinokhrngkarsahrbekbrwbrwmsuxesri thi khunsamarthchwyid khwamyx khaxthibayBNT162b2 vaccine efficacy data png English Cumulative incidence curves for the first COVID 19 occurrence after first dose of Tozinameran BNT162b2 or placebo all available efficacy population in double blind clinical trial submitted to the U S FDA for EUA by Pfizer BioNTech red placebo blue BNT162b2 wnthi 17 phvscikayn ph s 2563aehlngthima https www fda gov media 144245 download p30 phusrangsrrkh U S Food and Drug Administration and Pfizer Inc karxnuyatichsiththi Public domain Public domain false falseThis chart is ineligible for copyright and therefore in the public domain because it consists entirely of information that is common property and contains no original authorship For more information see Commons Threshold of originality Charts العربية Deutsch English francais italiano makedonski romană russkij 中文 khabrryayodyyxithyephimkhabrryaythrrthdediywephuxkhyaykhwamwaiflnimixairxngkvsCumulative incidence curves for symptomatic COVID 19 infections after the first dose of Tozinameran BNT162b2 or placebo in double blind clinical trial red placebo blue BNT162b2 ixethmthiaesdngxyuiniflniprakxbdwy prawtiifl khlikwnthi ewlaephuxduiflthipraktinkhnann wnthi ewlarupyxkhnadphuichkhwamehn pccubn15 08 1 mkrakhm 25641 120 860 127 kiolibt WikmozUploaded a work by U S Food and Drug Administration and Pfizer Inc from https www fda gov media 144245 download p30 with UploadWizard hnathimiphaphni hnatxipni oyngmathiphaphni wkhsinokhwid 19 wkhsinokhwid 19 khxngifesxr ibxxnethkh karichiflswnklang wikixuntxipniichiflni karichbn cs wikipedia org Vakcina Pfizer BioNTech proti covidu 19 Vakcina proti covidu 19 karichbn de wikipedia org Tozinameran karichbn el wikipedia org Embolio COVID 19 Xrhsths Ramnoysia proxeiro Embolio COVID 19 twn Pfizer BioNTech karichbn en wikipedia org Pfizer BioNTech COVID 19 vaccine COVID 19 vaccine clinical research karichbn ja wikipedia org COVID 19ワクチン karichbn sl wikipedia org Cepivo proti covidu 19 karichbn vi wikipedia org Vắc xin COVID 19 ekhathungcak https th wikipedia org wiki ifl BNT162b2 vaccine efficacy data png, wikipedia, วิกิ หนังสือ, หนังสือ, ห้องสมุด,
